MedTrace Logo

Pilot Observational Study and Safety Analysis of FL Nourish Capsules in Cancer Patients in Remission

NCT06807515 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2025-04-09

No results posted yet for this study

Summary

This is a single-centre, observational prospective study of cancer patients in remission administering FL Nourish capsules (FLNC), a proprietary Chinese Medicine herbal supplement, for the treatment of symptoms associated with qi deficiency and blood stasis syndrome.

Conditions

Sponsors & Collaborators

  • Thong Chai Institute of Medical Research

    lead OTHER

Principal Investigators

  • Huang Fang Zheng, PhD, BS · Singapore Thong Chai Medical Institution

  • Renyuan Shen, MS, BA · Singapore Thong Chai Medical Institution

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-10
Primary Completion
2027-02-09
Completion
2027-08-09

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06807515 on ClinicalTrials.gov